MCF-7: The first hormone-responsive breast cancer cell line

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3071-3078

  Levenson, Anait S ^a   Jordan, V Craig ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GROWTH FACTOR; MONOCLONAL ANTIBODY; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROGESTERONE RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA;

BREAST CANCER; CELL DIVISION; CELL STRAIN MCF 7; HORMONE RESISTANCE; HUMAN; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; REVIEW; TUMOR GROWTH;

AGED; BREAST NEOPLASMS; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HISTORY, 20TH CENTURY; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030802967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Soule, H. D., Vazquez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
2. Brooks, S. C., Locke, E. R., and Soule, H. D. Estrogen receptors in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem., 248: 6251-6253, 1973.
3. Lippman, M. E., and Bolan, G. Oestrogen-responsive human breast cancer in long-term tissue culture. Nature (Lond), 256: 592-593, 1975.
4. Cole M, Jones C. T., and Todd I. D. H. A new antioestrogenic agent in late breast cancer: an early clinical appraisal of ICI 46,474. Br. J. Cancer, 25: 270-275, 1971.
5. Horwitz, K. B., Costlow, M. E., and McGuire, W. L. MCF-7: a human breast cancer cell line with estrogen, androgen, progesterone and glucocorticoid receptors. Steroids, 26: 785-795, 1975.
6. Horwitz, K. B., and McGuire, W. L. Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J. Biol. Chem., 253: 2223-2228, 1978.
7. Horwitz, K. B., and McGuire W. L. Nuclear mechanism of estrogen action: effects of estradiol and antiestrogens on estrogen receptors and nuclear receptor processing. J. Biol. Chem., 253: 8185-8191, 1978.
8. Horwitz, K. B., McGuire, W. L., Pearson, O. H., and Segaloff, A. Predicting response to endocrine therapy in human breast cancer: a hypothesis. Science (Washington DC), 189: 726-727, 1975.
9. Horwitz, K. B., Koseki, Y., and McGuire, W. L. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology, 103: 1742-1751, 1978.
10. Jordan, V. C., and Murphy, C. S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev., 11: 578-610, 1990.
11. Lippman, M. E., Bolan, G., and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res., 36: 4595-4601, 1976.
12. l phase of the cell cycle. Eur. J. Cancer Clin. Oncol., 19: 615-621, 1983.
13. Sutherland, R. L., Hall, R. E., and Taylor, I. W. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau phase cells. Cancer Res., 43: 3998-4006, 1983.
14. Osborne, C. K., Boldt, D. H., Clark, G. M., and Trent, J. M. Effect of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G, phase. Cancer Res., 43: 3583-3585, 1983.